RETRACTED: Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) has been called the disease of the century with significant clinical and socioeconomic impacts. Pharmacological treatment has limited efficacy and only provides symptomatic relief without long‐term cure. Accordingly, there is an urgent need to develop novel and effective medications for AD. Stem cell‐based therapy is a promising approach to handling neurodegenerative diseases. Therefore, the current study aimed to explore the possible therapeutic role of single intravenous injection of bone marrow derived mesenchymal stem cells (BM‐MSCs) after 4 months in management of AD in the experimental model. The work also extended to compare the therapeutic potential of BM‐MSCs with 2 conventional therapies of AD; rivastigmine and cerebrolysin administered daily. BM‐MSCs were able to home at the injured brains and produced significant increases in the number of positive cells for choline acetyltransferase (ChAT) and survivin expression, as well as selective AD indicator‐1 (seladin‐1) and nestin gene expression. Histopathological examination indicated that BM‐MSCs could remove beta‐amyloid plaques from hippocampus. Significant improvement in these biomarkers was similar to or better sometimes than the reference drugs, clearly showing the potential therapeutic role of BM‐MSCs against AD through their anti‐apoptotic, neurogenic and immunomodulatory properties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Animal models of Alzheimer's disease and frontotemporal dementia
Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676
Entorhinal cortex pathology in Alzheimer's disease
van Hoesen, G. W., Hyman, B. T., & Damasio, A. R. (1991) · Hippocampus · doi:10.1002/hipo.450010102 · Cited by 475 · cited 1×
“The photomicrographs of brain tissue sections of untreated ADgroup showed various sizes of amyloid plaques formation in the hippocampus associated with oedema, hypoplasia, congested blood capillaries and neuronal degeneration, these findings being in agreement with Van Hoesen et al. (1991).”
ResultShin, J. Y., Park, H. J., Kim, H. N., Oh, S. H., Bae, J.-S., Ha, H.-J., & Lee, P. H. (2014) · Autophagy · doi:10.4161/auto.26508 · Cited by 243
Lee, J. K., Jin, H. K., & Bae, J.-S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.059 · Cited by 189
Ma, W., Maric, D., Li, B., Hu, Q., Andreadis, J. D., Grant, G. M., Liu, Q., Shaffer, K. M., Chang, Y. H., Zhang, L., et al. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00010.x · Cited by 161
Neurotoxic effect of enteral aluminium
Bilkei-Gorzó, A. (1993) · Food and Chemical Toxicology · doi:10.1016/0278-6915(93)90191-z · Cited by 84
Cited by
Regenerative Stem Cell Therapy for Neurodegenerative Diseases: An Overview
Sivandzade, F., & Cucullo, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042153 · Cited by 224
Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases
Lo Furno, D., Mannino, G., & Giuffrida, R. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26192 · Cited by 177
Mesenchymal Stem Cell Therapy and Alzheimer’s Disease: Current Status and Future Perspectives
Kim, J., Lee, Y., Lee, S., Kim, K., Song, M., & Lee, J. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200219 · Cited by 73
“In an AD rat model with hippocampal A (cid:2) lesions, a single intravenous injection of BM-MSCs resulted in the complete elimination of A (cid:2) [38].”
Stem cell therapy in Alzheimer’s disease: possible benefits and limiting drawbacks
Alipour, M., Nabavi, S. M., Arab, L., Vosough, M., Pakdaman, H., Ehsani, E., & Shahpasand, K. (2019) · Molecular Biology Reports · doi:10.1007/s11033-018-4499-7 · Cited by 63
Metadata
- Authors
- Salem, A. M., Ahmed, H. H., Atta, H. M., Ghazy, M. A., & Aglan, H. A.
- Venue
- Cell Biology International
- Publisher
- Wiley
- Published
- 2014-07-17
- Volume
- 38
- Issue
- 12
- Pages
- 1367-1383
- ISSN
- 1065-6995 (ISSN-L)
- 1095-8355
- OpenAlex
- W2106585367
- Cited by
- 56
- References
- 7
- FWCI
- 4.50
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.